Literature DB >> 26225180

The utility of provincial AS guidelines.

Munir Jamal1.   

Abstract

Year:  2015        PMID: 26225180      PMCID: PMC4479653          DOI: 10.5489/cuaj.3041

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  6 in total

1.  Recommendations on screening for prostate cancer with the prostate-specific antigen test.

Authors:  Neil Bell; Sarah Connor Gorber; Amanda Shane; Michel Joffres; Harminder Singh; James Dickinson; Elizabeth Shaw; Lesley Dunfield; Marcello Tonelli
Journal:  CMAJ       Date:  2014-10-27       Impact factor: 8.262

2.  Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

Authors:  Richard Choo; Laurence Klotz; Cyril Danjoux; Gerard C Morton; Gerrit DeBoer; Ewa Szumacher; Neil Fleshner; Peter Bunting; George Hruby
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

3.  The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.

Authors:  Matthew R Cooperberg; David J Pasta; Eric P Elkin; Mark S Litwin; David M Latini; Janeen Du Chane; Peter R Carroll
Journal:  J Urol       Date:  2005-06       Impact factor: 7.450

4.  Conditional probability of reclassification in an active surveillance program for prostate cancer.

Authors:  Ridwan Alam; H Ballentine Carter; Patricia Landis; Jonathan I Epstein; Mufaddal Mamawala
Journal:  J Urol       Date:  2015-01-06       Impact factor: 7.450

5.  Active surveillance for the management of localized prostate cancer: Guideline recommendations.

Authors:  Chris Morash; Rovena Tey; Chika Agbassi; Laurence Klotz; Tom McGowan; John Srigley; Andrew Evans
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

6.  Contemporary trends in low risk prostate cancer: risk assessment and treatment.

Authors:  Matthew R Cooperberg; Jeannette M Broering; Philip W Kantoff; Peter R Carroll
Journal:  J Urol       Date:  2007-07-20       Impact factor: 7.450

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.